Arrowhead Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ARWR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Apr 24	SellUS$168,180	James Hamilton	Individual	6,000	US$28.03
20 Mar 24	BuyUS$82,990	Hongbo Lu	Individual	3,000	US$28.00
06 Mar 24	SellUS$1,407,600	Kenneth Myszkowski	Individual	40,000	US$35.19
20 Nov 23	SellUS$567,315	Javier San Martin	Individual	19,700	US$29.00
28 Sep 23	SellUS$40,812	Victoria Vakiener	Individual	1,550	US$26.33
03 Jul 23	SellUS$315,142	Tracie Oliver	Individual	8,925	US$35.31
30 Jun 23	SellUS$106,590	James Hamilton	Individual	3,000	US$35.53
27 Jun 23	SellUS$543,000	Kenneth Myszkowski	Individual	15,000	US$36.20

Insider Trading Volume

Insider Buying: ARWR insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARWR?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,532	0.00284%
State or Government	62,506	0.0503%
Individual Insiders	4,881,921	3.93%
Hedge Funds	8,555,555	6.89%
General Public	21,999,685	17.7%
Institutions	88,697,031	71.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.2%.

Top Shareholders

Top 25 shareholders own 66.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.4%	BlackRock, Inc.	15,346,637	US$396.6m	15.4%	0.01%
9.99%	The Vanguard Group, Inc.	12,404,050	US$320.5m	16.2%	0.01%
6.89%	Avoro Capital Advisors LLC	8,555,555	US$221.1m	657%	2.72%
5.28%	State Street Global Advisors, Inc.	6,560,703	US$169.5m	-3.87%	0.01%
5.15%	FMR LLC	6,394,030	US$165.2m	89.7%	0.01%
3.33%	Slate Path Capital LP	4,139,000	US$107.0m	211%	2.0%
2.99%	Christopher Anzalone	3,715,048	US$96.0m	87.3%	no data
2.44%	Artal Group S.A.	3,036,668	US$78.5m	195%	1.87%
2.22%	Geode Capital Management, LLC	2,754,634	US$71.2m	18.4%	0.01%
1.9%	JP Morgan Asset Management	2,365,162	US$61.1m	-4.83%	0.01%
1.47%	T. Rowe Price Group, Inc.	1,830,019	US$47.3m	2,920%	no data
1.11%	UBS Asset Management AG	1,384,821	US$35.8m	-5.14%	no data
1.07%	Credit Suisse Asset Management (Switzerland) Ltd.	1,332,032	US$34.4m	-6.28%	0.03%
1.06%	Norges Bank Investment Management	1,321,927	US$34.2m	0%	no data
1.05%	Northern Trust Global Investments	1,300,649	US$33.6m	5.78%	0.01%
0.99%	Rokos Capital Management LLP	1,229,148	US$31.8m	0%	0.81%
0.99%	Pictet Asset Management Limited	1,225,987	US$31.7m	10,400%	0.02%
0.84%	BNY Asset Management	1,047,677	US$27.1m	10.2%	no data
0.8%	Columbia Management Investment Advisers, LLC	997,297	US$25.8m	7.4%	0.01%
0.79%	Charles Schwab Investment Management, Inc.	983,755	US$25.4m	16.3%	no data
0.75%	Morgan Stanley, Investment Banking and Brokerage Investments	935,915	US$24.2m	30%	no data
0.73%	Aquilo Capital Management, LLC	908,474	US$23.5m	0%	20.03%
0.71%	Goldman Sachs Group, Investment Banking and Securities Investments	875,787	US$22.6m	-1.48%	0.01%
0.66%	Western Financial Corporation	820,239	US$21.2m	0%	13.35%
0.6%	Citadel Advisors LLC	741,897	US$19.2m	1,170%	0.02%